Paper156233
Inhibition of in vitro cytotoxic responses by BCG-induced macrophage-like suppressor cells. II. Suppression occurs at the level of a "helper" T cell.
Klimpel GR and 2 others. J Immunol, 1979. Cited by 43 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of in vitro cytotoxic responses by BCG-induced macrophage-like suppressor cells. II. Suppression occurs at the level of a "helper" T cell. Papers, record 156233. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/156233
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of in vitro cytotoxic responses by BCG-induced macrophage-like suppressor cells. II. Suppression occurs at the level of a "helper" T cell.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| BCG Vaccine | Major topic |
| Cytotoxicity, Immunologic | Major topic |
| Macrophages | Major topic |
| Mycobacterium bovis | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| Cells, Cultured | |
| Immunoglobulin Fc Fragments | |
| Lymphocyte Culture Test, Mixed | |
| Male | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred C57BL | |
| Mice, Inbred CBA | |
| Mice, Inbred DBA | |
| Rabbits | |
| Solubility | |
| Spleen | |
| Time Factors |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38515752 | VapC12 ribonuclease toxin modulates host immune response during Mycobacterium tuberculosis infection. | Front Immunol | 2024 | https://conductscience.org/library/papers/38515752 | PubMed |
| 33955457 | Effective Host-Directed Therapy for Tuberculosis by Depletion of Myeloid-Derived Suppressor Cells and Related Cells Using a Diphtheria Toxin Fusion Protein. | J Infect Dis | 2021 | https://conductscience.org/library/papers/33955457 | PubMed |
| 31114578 | The Emerging Role of Myeloid-Derived Suppressor Cells in Tuberculosis. | Front Immunol | 2019 | https://conductscience.org/library/papers/31114578 | PubMed |
| 6997425 | Macrophages elicited with heat-killed bacillus Calomette-Guérin protect C57BL/6J mice against a syngeneic melanoma. | J Exp Med | 1980 | https://conductscience.org/library/papers/6997425 | PubMed |
| 6337092 | Deficit of interleukin 2 production associated with impaired T-cell proliferative responses in Mycobacterium lepraemurium infection. | Infect Immun | 1983 | https://conductscience.org/library/papers/6337092 | PubMed |
| 6234012 | Suppressor T cells in BCG-treated mice interfere with an in vivo specific antitumoral immune response. | Br J Cancer | 1984 | https://conductscience.org/library/papers/6234012 | PubMed |
| 6216203 | In vivo macrophage suppression of delayed hypersensitivity in the guinea-pig. | Immunology | 1982 | https://conductscience.org/library/papers/6216203 | PubMed |
| 6140268 | Regulation of the immune response by prostaglandins. | J Clin Immunol | 1983 | https://conductscience.org/library/papers/6140268 | PubMed |
| 3779716 | BCG immunotherapy in stage I melanoma patients. Does it influence prognosis determined by HLA-DR expression in high-risk primary tumors? | Cancer Immunol Immunother | 1986 | https://conductscience.org/library/papers/3779716 | PubMed |
| 3731206 | Immunogenicity of viable tumor cells. A comparison of xenogenized tumor cells and BCG-tumor cell mixtures. | Cancer Immunol Immunother | 1986 | https://conductscience.org/library/papers/3731206 | PubMed |
| 3081445 | Mechanisms underlying the depressed production of interleukin-2 in spleen and lymph node cell cultures of mice infected with Mycobacterium bovis BCG. | Infect Immun | 1986 | https://conductscience.org/library/papers/3081445 | PubMed |
| 2965973 | Induction by an immunogenic immunomodulating agent of nonspecific T cell suppression of lymphocyte responsiveness in MLR but not of antibody production. | Cancer Immunol Immunother | 1988 | https://conductscience.org/library/papers/2965973 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/156233
GET https://conductscience.org/api/papers/v1/156233/authors